Patient-Centered Intervention to Reduce Cancer Patients' Financial Toxicity

Study summary

The purpose of this study is to incorporate feedback from cancer patients and providers to adapt, implement, and test an intervention. The intervention aims to prompt screening for financial distress, facilitate discussions about care costs with cancer patients, support health insurance selection, and ultimately reduce cancer patients' financial toxicity associated with cancer care.

Ask AI to explain this study

Start here

Key things to know

Main goalHealth Services Research

This describes the study’s primary purpose.

What is being studiedI Can PIC and Historical control survey

Plus 2 other study approaches.

Who it may be forGynecologic Cancer · Colorectal Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated May 9, 2023 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Washington University School of Medicine

Study sponsor

Study overview

What this study is about

Purpose: Health Services Research
Study type: Interventional
Phase: Not applicable
Sponsor: Washington University School of Medicine
Interventions being studied: Behavioral: I Can PIC; Other: Historical control survey; Other: Post-intervention survey (I Can PIC participants); Other: Follow-Up survey (I Can PIC participants)

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach

Supportive or behavioral care→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Eligibility criteria for I Can Pic Arm only:
18 years of age or older
Must have been diagnosed with colorectal cancer, lung cancer, or gynecologic cancer \< 5 months ago and be patients of one of the 15 providers
This cancer diagnosis must be the first and primary diagnosis

Reasons someone may not be able to joinExclusion criteria

Not able to read and understand English
Cannot give informed consent due to cognitive or emotional barriers

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Washington University School of MedicineSt Louis, Missouri

Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 9, 2023. Always confirm current availability with the study team.

View original record ↗